Free Trial

Conduit Pharmaceuticals (CDTTW) Competitors

$0.02 +0.00 (+17.19%)
As of 07/25/2025 03:14 PM Eastern

CDTTW vs. ATNFW, SXTPW, DRTSW, APLMW, BCTXW, CDIOW, CELUW, CEROW, CINGW, and CLNNW

Should you be buying Conduit Pharmaceuticals stock or one of its competitors? The main competitors of Conduit Pharmaceuticals include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Celularity (CELUW), CERo Therapeutics (CEROW), Cingulate (CINGW), and Clene (CLNNW). These companies are all part of the "biotechnology" industry.

Conduit Pharmaceuticals vs. Its Competitors

Conduit Pharmaceuticals (NASDAQ:CDTTW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, profitability, dividends, risk and analyst recommendations.

In the previous week, Conduit Pharmaceuticals and Conduit Pharmaceuticals both had 1 articles in the media. 180 Life Sciences' average media sentiment score of 1.89 beat Conduit Pharmaceuticals' score of 1.87 indicating that 180 Life Sciences is being referred to more favorably in the news media.

Company Overall Sentiment
Conduit Pharmaceuticals Very Positive
180 Life Sciences Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Conduit PharmaceuticalsN/AN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Conduit PharmaceuticalsN/A N/A N/A
180 Life Sciences N/A N/A N/A

Summary

180 Life Sciences beats Conduit Pharmaceuticals on 1 of the 1 factors compared between the two stocks.

Get Conduit Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for CDTTW and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CDTTW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CDTTW vs. The Competition

MetricConduit PharmaceuticalsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$136.79M$5.69B$9.50B
Dividend YieldN/A3.74%4.58%4.01%
P/E RatioN/A3.7528.1020.05
Price / SalesN/A4,471.55432.4890.19
Price / CashN/A13.1936.2258.56
Price / BookN/A42.328.665.87
Net IncomeN/A-$90.99M$3.25B$258.55M
7 Day PerformanceN/A4.83%4.22%3.73%
1 Month PerformanceN/A8.36%10.51%11.75%
1 Year PerformanceN/A195.89%34.40%18.03%

Conduit Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CDTTW
Conduit Pharmaceuticals
N/A$0.02
+17.2%
N/A-55.9%$0.00N/A0.007Positive News
Gap Up
ATNFW
180 Life Sciences
N/A$0.01
+13.7%
N/A+22.2%$0.00N/A0.007Gap Down
SXTPW
60 Degrees Pharmaceuticals
N/A$0.09
+23.9%
N/A-31.5%$0.00$665.45K0.002Gap Up
DRTSW
Alpha Tau Medical
N/A$0.23
-13.3%
N/A+5.9%$0.00N/A0.0080Gap Down
APLMW
Apollomics
N/A$0.03
-4.3%
N/A+149.3%$0.00N/A0.0059
BCTXW
BriaCell Therapeutics
N/A$0.07
+1.6%
N/A-78.1%$0.00N/A0.008Gap Up
CDIOW
Cardio Diagnostics
N/A$0.01
flat
N/A-65.0%$0.00$19.90K0.007Gap Up
High Trading Volume
CELUW
Celularity
N/A$0.05
flat
N/A+242.5%$0.00$54.22M0.00220Gap Down
CEROW
CERo Therapeutics
N/A$0.03
-3.3%
N/A-17.5%$0.00N/A0.008Gap Down
CINGW
Cingulate
N/A$0.15
-14.2%
N/A+1,400.0%$0.00N/A0.0020Gap Down
High Trading Volume
CLNNW
Clene
N/A$0.03
-0.7%
N/A+14.1%$0.00$350K0.00100

Related Companies and Tools


This page (NASDAQ:CDTTW) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners